TrialInternational journal of clinical oncology2026

Efficacy of bepotastine compared with hydroxyzine in preventing rituximab-induced infusion-related reactions in non-hodgkin lymphoma patients: a phase II, double-blind, multicenter, and randomized trial.

Yumi Kitahiro et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.